Skip to Main Content

CMS Issues ICD-10 Revisions to NCDs Relevant to Radiology

Nov. 15, 2023

The Centers for Medicare and Medicaid Services (CMS) recently released Change Request (CR) 13391, which contains International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) coding revisions to various National Coverage Determinations (NCD). Modifications include NCDs relevant to radiology:

  • NCD 150.3 Bone Mass Measurements. Medicare administrative contractors (MACs) are instructed to add ICD-10 diagnosis codes M80.0B1A, M80.0B2A, M80.8B1A, and M80.8B2A.
  • NCD 220.4 Mammograms. MACs are instructed to add ICD-10 diagnosis codes for mammographic density found on imaging of breast: R92.30, R92.311, R92.312, R92.313, R92.321, R92.322, R92.323, R92.331, R92.332, R92.333, R92.341, R92.342 and R92.343.
  • NCD 220.6.17 Positron Emission Tomography (FDG) for Oncologic Conditions. CMS instructs MACs to end-date ICD-10 diagnosis code D48.1 and add ICD-10 diagnosis codes D48.19, Other specified neoplasm of uncertain behavior of connective and other soft tissue.

These changes took effect Oct. 1. See Change Request 13391 further details, including a full list of affected NCDs.

For more information, contact Maria Tran, American College of Radiology® Director of Economic Policy.


Related ACR News

  • HRSA Breast Cancer Screening for Average Risk Guideline

    The U.S. Department of Health and Human Services Health Resources and Services Administration finalized its proposal for the Breast Cancer Screening for Women at Average Risk guideline.

    Read more

  • ACR Comments on Draft HRSA Breast Cancer Screening Recommendations

    The American College of Radiology® (ACR®) submitted comments this week on draft recommendations for the Health Resources and Services Administration (HRSA)-supported Women's Preventive Services Guidelines , including for breast cancer screening.

    Read more

  • Navigating Breast Imaging Guidelines

    In April 2024, the U.S. Preventive Services Task Force changed the recommendations for imaging of non–BRCA-related breast cancer. The recommendations now state that biennial screening mammography is recommended for women ages 40 to 74, a pattern formerly suggested for women at least 50 years old.

    Read more